Investigational Microbiome Therapeutic SER-109 Reduces Risk for CDI Recurrence
Researchers evaluated the safety of SER-109 and its effect on CDI recurrence among adult outpatients.
Diagnosis & Disease Information
Fecal Microbiota Transplantation Effective Option for Pediatric C difficile Infection
Investigators conducted a systematic review and meta-analysis to assess the safety and efficacy of fecal microbiota transplantation for C difficile infection in pediatric patients.
Oral Microbiome Therapy Sustains Clinical Cure for Recurrent CDI
Presenting at DDW 2022, researchers evaluated data from the PRISM3 placebo-controlled trial and the PRISM-EXT open-label extension trial of CP101, an investigational microbiome therapeutic.
Management of Clostridioides difficile Infection in Adults: 2021 Clinical Practice Guidelines
A multidisciplinary panel comprising members from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America created guidelines for health care professionals caring for patients with C difficile infection.
Low Immune Response to Clostridioides difficile Treatment in Immunosuppressed Patients
Investigators assessed the immune response to Clostridioides difficile in immunocompromised patients.
- Loading...
Loading...
Loading... 
Loading...